External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib data

por Kassir, Nastya, Chan, Phyllis, Dang, Steve, Bruno, René
Publicado 2023

Machine Learning for Exposure-Response Analysis: Methodological Considerations and Confirmation of Their Importance via Computational Experimentations

por Harun, Rashed, Yang, Eric, Kassir, Nastya, Zhang, Wenhui, Lu, James
Publicado 2023

Population Pharmacokinetics and Pharmacodynamics of Ontamalimab (SHP647), a Fully Human Monoclonal Antibody Against Mucosal Addressin Cell Adhesion Molecule‐1 (MAdCAM‐1), in Patien...

por Wang, Yi, Marier, Jean‐Francois, Lavigne, Jean, Kassir, Nastya, Martin, Patrick
Publicado 2020

Pharmacokinetics, Pharmacodynamics, and Exposure‐Response of Lanadelumab for Hereditary Angioedema

por Wang, Yi, Marier, Jean-Francois, Kassir, Nastya, Chang, Colin, Martin, Patrick
Publicado 2020

A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score

por Moein, Anita, Langenhorst, Jurgen, Plan, Elodie L., Jin, Jin Y., Kågedal, Matts, Kassir, Nastya
Publicado 2023

Population pharmacokinetic and exposure–response analysis of apremilast in Japanese subjects with moderate to severe psoriasis

por Okubo, Yukari, Ohtsuki, Mamitaro, Komine, Mayumi, Imafuku, Shinichi, Kassir, Nastya, Petric, Rosemary, Nemoto, Osamu
Publicado 2021

Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study

por Lapeyraque, Anne-Laure, Kassir, Nastya, Théorêt, Yves, Krajinovic, Maja, Clermont, Marie-José, Litalien, Catherine, Phan, Véronique
Publicado 2014

Population Pharmacokinetics of Tenecteplase in Patients With Acute Myocardial Infarction and Application to Patients With Acute Ischemic Stroke

por Tang, Fei, Langenhorst, Jurgen, Dang, Steve, Kassir, Nastya, Owen, Ryan, Purdon, Barbara, Magnusson, Mats O., Deng, Rong
Publicado 2022

Exposure‐response relationships of etrolizumab in patients with moderately‐to‐severely active ulcerative colitis

por Kassir, Nastya, Zhu, Rui, Moein, Anita, Langenhorst, Jurgen, Ribbing, Jakob, Zhang, Rong, Tang, Meina T., Oh, Young S., Zhang, Wenhui
Publicado 2022

Population pharmacokinetic analysis of etrolizumab in patients with moderately‐to‐severely active ulcerative colitis

por Moein, Anita, Lu, Tong, Jönsson, Siv, Ribbing, Jakob, Kassir, Nastya, Zhang, Wenhui, Sperinde, Gizette, Zhang, Rong, Tang, Meina, Oh, Young S., Bruno, Rene, Zhu, Rui
Publicado 2022

Population Pharmacokinetics and Exposure–Response of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With Myelodysplastic Syndromes

por Chen, Nianhang, Kassir, Nastya, Laadem, Abderrahmane, Maxwell, Stephen E., Sriraman, Priya, Giuseppi, Ana Carolina, Ritland, Steve, Linde, Peter G., Budda, Balasubrahmanyam, Reynolds, Joseph G., Zhou, Simon, Palmisano, Maria
Publicado 2020

Population Pharmacokinetics and Exposure‐Response Relationship of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With β‐Thalassemia

por Chen, Nianhang, Kassir, Nastya, Laadem, Abderrahmane, Giuseppi, Ana Carolina, Shetty, Jeevan, Maxwell, Stephen E., Sriraman, Priya, Ritland, Steve, Linde, Peter G., Budda, Balasubrahmanyam, Reynolds, Joseph G., Zhou, Simon, Palmisano, Maria
Publicado 2020

Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study

por Ben Hassine, Khalil, Nava, Tiago, Théoret, Yves, Nath, Christa E., Daali, Youssef, Kassir, Nastya, Lewis, Victor, Bredius, Robbert G. M., Shaw, Peter J., Bittencourt, Henrique, Krajinovic, Maja, Uppugunduri, Chakradhara Rao Satyanarayana, Ansari, Marc
Publicado 2021